Delivery Order SPE2DR25D3301-SPE2DR26F19CC
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,532.28 for Fluticasone Propionate HFA 110 MCG inhalers (12GM units), with an ultimate completion date of August 11, 2025. This contract was competitively awarded on August 8, 2025, under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed to AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.24 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on November 26, 2025, with completion expected by November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,379.83 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 23, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.14 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. This competitively awarded, firm fixed-price order was placed on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams) with a ceiling value of $9,431.13. This non-set-aside, competitively awarded contract operates under firm fixed pricing and requires completion by June 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a $1,103.54 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers under a firm fixed-price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office division,...
- The Defense Logistics Agency awarded a delivery order valued at $1,781.18 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg 12 gm inhalers on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract is a firm fixed price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,458.34 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. The contract is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's broader pharmaceutical supply agreement with DLA. This award was issued on July 10, 2025, with an ultimate completion date of July 11, 2025, and will be performed at AmerisourceBergen's...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19CCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 MCG inhalers (12 GM) valued at $8,696.48 under a firm fixed-price contract. The award was made competitively without a set-aside designation and is scheduled for completion by December 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its established role as a critical pharmaceutical supplier to federal medical procurement systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order for Fluticasone represents a routine pharmaceutical supply transaction consistent with AmerisourceBergen's extensive portfolio of federal medical product deliveries, which serve defense health organizations, the U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 12/4/25 |